Elocalcitol

N/A

Report date: 2022/04/22 15:56:50
NME

Base Information

Drug NameElocalcitol
Drug Alias NameBXL-628Ro-26-9228
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsUrinary Bladder, OveractiveProstatitisProstatic Hyperplasia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCosmo PharmaceuticalsF. Hoffmann-La Roche LtdCyan Bio Inc +[4] 
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveProstatitisProstatic Hyperplasia +[4] 

Other Information

ATC CodeN/A
Related LinksN/A